Key Strengths

• Established mammalian cell banks for protein and antibody production are the starting point for STAR^® technology, thus specially engineered mammalian cells are not needed.

• The STAR^® technology allows for very rapid stable mammalian cell clone generation.

• The STAR^® technology typically yields stable mammalian cell clones that produce 5 to 10 fold higher antibody or other therapeutic proteins as compared to cell clones generated without STAR^® technology.